Literature DB >> 22282408

Application of ultra-performance liquid chromatography coupled with mass spectrometry to metabonomic study on spontaneously hypertensive rats and intervention effects of Ping Gan prescription.

Haiqiang Jiang1, Lei Nie, Yunlun Li, Jun Xie.   

Abstract

This study describes the metabonomic characters of the spontaneously hypertensive rats (SHR) and intervention effects of Ping Gan prescription. Ultra performance LC coupled with Q-TOF MS (UPLC/MS-Q-TOF) was employed to develop a metabonomic method of the plasma of SHR. There was a significant difference in metabolic profiling observed between predose group of Wistar Kyoto rats and model group (SHR) by using the principal components analysis (PCA). Some significant changes in metabolites such as LysoPC(22:6), LysoPC(20:4), LysoPC(18:1), cholylglycine, PE(P-16:0e/0:0), sphingosine-1-phosphate, and 2-oxo-4-methylthio butanoic acid were identified. These biochemical changes were associated with the disturbance in sphingolipid metabolism and fat metabolism, which would be helpful to further understand the essence of hypertension and the therapeutic mechanism of Ping Gan prescription. This study suggests that the metabonomic method may be a valuable and feasible tool to explore the therapeutic effect and mechanism of traditional Chinese medicine (TCM).
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22282408     DOI: 10.1002/jssc.201100769

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  8 in total

1.  Blood pressure-lowering effect of Korean red ginseng associated with decreased circulating Lp-PLA2 activity and lysophosphatidylcholines and increased dihydrobiopterin level in prehypertensive subjects.

Authors:  Tae Woong Cha; Minjoo Kim; Minkyung Kim; Jey Sook Chae; Jong Ho Lee
Journal:  Hypertens Res       Date:  2016-02-04       Impact factor: 3.872

2.  RECENT ADVANCES IN ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR THE ANALYSIS OF TRADITIONAL CHINESE MEDICINE.

Authors:  Huilian Huang; Min Liu; Pei Chen
Journal:  Anal Lett       Date:  2014       Impact factor: 2.329

3.  Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols.

Authors:  Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Christopher K Barlow; Jeremy B Jowett; Claire Bellis; Thomas D Dyer; Matthew P Johnson; David L Rainwater; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; John Blangero; Joanne E Curran
Journal:  Hypertension       Date:  2013-06-24       Impact factor: 10.190

Review 4.  Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research.

Authors:  Zhexue Wu; Jong Cheol Shon; Kwang-Hyeon Liu
Journal:  J Lifestyle Med       Date:  2014-03-31

5.  QGQS Granule in SHR Serum Metabonomics Study Based on Tools of UPLC-Q-TOF and Renin-Angiotensin-Aldosterone System Form Protein Profilin-1.

Authors:  Ke Li; Caicai Li; Jialong Wang; Hanming Cui; Yu Dong; Ruihua Liu; Yuanhui Hu
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-06       Impact factor: 2.629

6.  LC-MS-Based Lipidomic Analysis of Serum Samples from Spontaneously Hypertensive Rats Treated with an Extract of Acanthopanax sessiliflorus Fruits.

Authors:  Dae Young Lee; Bo-Ram Choi; Dahye Yoon; Hyoung-Geun Kim; Min-Ho Lee; Geum-Soog Kim; Young-Seob Lee
Journal:  Molecules       Date:  2020-07-17       Impact factor: 4.411

7.  Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress.

Authors:  Minjoo Kim; Saem Jung; Su Yeon Kim; Sang-Hyun Lee; Jong Ho Lee
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

8.  Antihypertensive activity of oleanolic acid is mediated via downregulation of secretory phospholipase A2 and fatty acid synthase in spontaneously hypertensive rats.

Authors:  Shiming Zhang; Yuecheng Liu; Xiaoming Wang; Zhenhua Tian; Dongmei Qi; Yunlun Li; Haiqiang Jiang
Journal:  Int J Mol Med       Date:  2020-09-30       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.